Tatyana Dubnikov

632 total citations
11 papers, 448 citations indexed

About

Tatyana Dubnikov is a scholar working on Molecular Biology, Cell Biology and Aging. According to data from OpenAlex, Tatyana Dubnikov has authored 11 papers receiving a total of 448 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 3 papers in Cell Biology and 3 papers in Aging. Recurrent topics in Tatyana Dubnikov's work include Prion Diseases and Protein Misfolding (3 papers), Genetics, Aging, and Longevity in Model Organisms (3 papers) and CAR-T cell therapy research (2 papers). Tatyana Dubnikov is often cited by papers focused on Prion Diseases and Protein Misfolding (3 papers), Genetics, Aging, and Longevity in Model Organisms (3 papers) and CAR-T cell therapy research (2 papers). Tatyana Dubnikov collaborates with scholars based in Israel, United States and Switzerland. Tatyana Dubnikov's co-authors include Ehud Cohen, Dvir Aran, Yechiel Friedlander, Ephrat Levy‐Lahad, Jeremy D. Kark, Michael Rosenberg, Benjamin Gläser, Asaf Hellman, Julio Wainstein and Tziona Ben‐Gedalya and has published in prestigious journals such as Journal of Neuroscience, Blood and Journal of Cell Science.

In The Last Decade

Tatyana Dubnikov

11 papers receiving 445 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tatyana Dubnikov Israel 8 331 99 82 75 64 11 448
Karyn L. Sheaffer United States 8 445 1.3× 124 1.3× 113 1.4× 60 0.8× 17 0.3× 9 582
Catherine Jin United States 5 606 1.8× 68 0.7× 32 0.4× 82 1.1× 40 0.6× 5 859
Shigeki Nishihara Japan 6 292 0.9× 76 0.8× 23 0.3× 48 0.6× 126 2.0× 16 447
Bret L. Bostwick United States 9 225 0.7× 215 2.2× 20 0.2× 43 0.6× 22 0.3× 17 414
Willemijn M. Passtoors Netherlands 8 159 0.5× 39 0.4× 119 1.5× 86 1.1× 19 0.3× 8 329
Stephanie Schatzman-Bone United States 3 288 0.9× 55 0.6× 19 0.2× 54 0.7× 28 0.4× 9 418
Handan Melike Dönertaş United Kingdom 11 194 0.6× 99 1.0× 87 1.1× 57 0.8× 9 0.1× 14 429
Ruud van der Breggen Netherlands 6 153 0.5× 63 0.6× 123 1.5× 82 1.1× 12 0.2× 7 321
Spivak Im Russia 9 217 0.7× 23 0.2× 85 1.0× 258 3.4× 16 0.3× 53 560
Kathryn A. Carbajal United States 5 159 0.5× 22 0.2× 66 0.8× 80 1.1× 27 0.4× 6 308

Countries citing papers authored by Tatyana Dubnikov

Since Specialization
Citations

This map shows the geographic impact of Tatyana Dubnikov's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tatyana Dubnikov with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tatyana Dubnikov more than expected).

Fields of papers citing papers by Tatyana Dubnikov

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tatyana Dubnikov. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tatyana Dubnikov. The network helps show where Tatyana Dubnikov may publish in the future.

Co-authorship network of co-authors of Tatyana Dubnikov

This figure shows the co-authorship network connecting the top 25 collaborators of Tatyana Dubnikov. A scholar is included among the top collaborators of Tatyana Dubnikov based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tatyana Dubnikov. Tatyana Dubnikov is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Kfir‐Erenfeld, Shlomit, Batia Avni, Sigal Grisariu, et al.. (2023). Safety and Efficacy of a Locally Produced Novel Anti-BCMA Chimeric Antigen Receptor T-Cell (CART) (HBI0101) for the Treatment of Relapsed and Refractory Multiple Myeloma. Blood. 142(Supplement 1). 4852–4852. 1 indexed citations
2.
Kfir‐Erenfeld, Shlomit, Sigal Grisariu, Batia Avni, et al.. (2023). Feasibility of a Novel Academic Anti-BCMA Chimeric Antigen Receptor T-Cell (CART) (HBI0101) for the Treatment of Relapsed and Refractory AL Amyloidosis. Blood. 142(Supplement 1). 538–538. 8 indexed citations
3.
Grisariu, Sigal, Batia Avni, Shlomo Elias, et al.. (2023). OA-34 Feasibility of a novel academic anti-BCMA chimeric antigen receptor T-cell (CART) (HBI0101) for the treatment of relapsed and refractory AL amyloidosis. Clinical Lymphoma Myeloma & Leukemia. 23. S21–S21. 1 indexed citations
4.
Kfir‐Erenfeld, Shlomit, Batia Avni, Miri Assayag, et al.. (2022). Development and manufacture of novel locally produced anti-BCMA CAR T cells for the treatment of relapsed/refractory multiple myeloma: results from a phase I clinical trial. Haematologica. 108(7). 1827–1839. 17 indexed citations
5.
Dubnikov, Tatyana & Ehud Cohen. (2017). The Emerging Roles of Early Protein Folding Events in the Secretory Pathway in the Development of Neurodegenerative Maladies. Frontiers in Neuroscience. 11. 48–48. 6 indexed citations
6.
Dubnikov, Tatyana, Tziona Ben‐Gedalya, & Ehud Cohen. (2016). Protein Quality Control in Health and Disease. Cold Spring Harbor Perspectives in Biology. 9(3). a023523–a023523. 60 indexed citations
7.
Dubnikov, Tatyana, Tziona Ben‐Gedalya, Robert C. Reiner, et al.. (2016). PrP-containing aggresomes are cytosolic components of an ER quality control mechanism. Journal of Cell Science. 129(19). 3635–3647. 9 indexed citations
8.
Dubnikov, Tatyana & Ehud Cohen. (2015). Proteostasis collapse, inter-tissue communication, and the regulation of aging at the organismal level. Frontiers in Genetics. 6. 80–80. 8 indexed citations
9.
Maman, Moria, et al.. (2013). A Neuronal GPCR is Critical for the Induction of the Heat Shock Response in the NematodeC. elegans. Journal of Neuroscience. 33(14). 6102–6111. 45 indexed citations
10.
Volovik, Yuli, Moria Maman, Tatyana Dubnikov, et al.. (2012). Temporal requirements of heat shock factor‐1 for longevity assurance. Aging Cell. 11(3). 491–499. 47 indexed citations
11.
Aran, Dvir, Jeremy D. Kark, Michael Rosenberg, et al.. (2011). Genome-wide survey reveals predisposing diabetes type 2-related DNA methylation variations in human peripheral blood. Human Molecular Genetics. 21(2). 371–383. 246 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Karyn L. Sheaffer Breakdown of academic impact, for papers by Catherine Jin Breakdown of academic impact, for papers by Shigeki Nishihara Breakdown of academic impact, for papers by Bret L. Bostwick Breakdown of academic impact, for papers by Willemijn M. Passtoors Breakdown of academic impact, for papers by Stephanie Schatzman-Bone Breakdown of academic impact, for papers by Handan Melike Dönertaş Breakdown of academic impact, for papers by Ruud van der Breggen Breakdown of academic impact, for papers by Spivak Im Breakdown of academic impact, for papers by Kathryn A. Carbajal
Rankless by CCL
2026